CADC up +20.25% percent right now. $CADC High is at 5.63

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
CADC up +20.25% percent right now. $CADC High is at 5.63 and the Low 4.13 with current volume of 68,573.

Recent News posted below.

CADC China Advanced Construction Recent Headline News

China ACM Reports 2014 Fiscal Year Results, Provides Quarterly Guidance for the First Quarter of Fiscal Year 2015 and Full Year Guidance for Fiscal Year 2015
GlobeNewswire - Wed Sep 24, 9:51AM CDT
China Advanced Construction Materials Group, Inc. (Nasdaq:CADC) ("China ACM" or the "Company", a provider of ready-mix concrete and related technical services in China, on September 23, 2014, announced its financial results for the fiscal year ended June 30, 2014.
CADC: 4.11 (+0.16)

China ACM to Host September 24 Conference Call on 2014 Fiscal Year Financial Results
Newsfile Corp - Thu Sep 18, 10:00PM CDT
full story)
CADC: 4.11 (+0.16)

China ACM Reports Second Quarter Fiscal Year 2014 Results, Provides Quarterly Guidance for the Third Quarter of Fiscal Year 2014, and Updates the Full Year Guidance for Fiscal Year 2014
GlobeNewswire - Wed Feb 12, 8:05PM CST
China Advanced Construction Materials Group, Inc. (Nasdaq:CADC) ("China ACM" or the "Company", a provider of ready-mix concrete and related technical services in China, on February 12, 2013, has announced its financial results for the second quarter ended December 31, 2013.
CADC: 4.11 (+0.16), SOI.VN: 0.080 (+0.010)

China ACM Announces Regained Compliance With the Listing Rule 5550(a)(2) for Continued Listing on The NASDAQ Capital Market
GlobeNewswire - Fri Aug 23, 7:05AM CDT
China Advanced Construction Materials Group, Inc. (Nasdaq:CADC) ("China ACM", the "Company", a provider of ready-mix concrete and related technical services in China, today announced that it received a letter from The NASDAQ Stock Market LLC ("NASDAQ" on August 20, 2013 notifying the Company that it had regained compliance with the $1.00 minimum bid price requirement for continued listing on The NASDAQ Capital Market. During the period between and including August 2, 2013 and August 19, 2013, the Company's common stock closed at a price higher than $1.00 per share. Accordingly, NASDAQ informed the Company that it regained compliance with Listing Rule 5550(a)(2), the minimum bid price rule, and the matter is now closed.
CADC: 4.11 (+0.16)

China ACM Announces Reverse Stock Split and Reincorporation in the State of Nevada
GlobeNewswire - Thu Aug 01, 3:10PM CDT
China Advanced Construction Materials Group, Inc. (Nasdaq:CADC) ("China ACM", the "Company", a provider of ready-mix concrete and related technical services in China, today announced that effective at 5:00 pm Eastern Time on August 1, 2013, the Company will effect a 1-for-12 reverse stock split of its common stock (the "Reverse Split".
CADC: 4.11 (+0.16)

China ACM to Report Third Quarter Fiscal Year 2013 Financial Results on May 16, 2013
Marketwire - Sun May 12, 12:43PM CDT
China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) ("China ACM", a provider of ready-mix concrete and related technical services in China, will host a conference call with a live webcast and a full Q&A session on May 16, 2013, at 8:00 a.m., Eastern Time, to discuss financial results for the third quarter of Fiscal Year 2013.
CADC: 4.11 (+0.16)

CADC, PICO, IVAN, USPH, FLL, KID Expected To Be Down Before Next Earnings Releases
M2 - Fri Apr 26, 6:58AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and December earnings reports. China Advanced Construction Materials Group Inc (NASDAQ:CADC), PICO HOLDINGS INCORPORATED (NASDAQICO), IVANHOE ENERGY INC (NASDAQ:IVAN), U S Physical Therapy Inc (NASDAQ:USPH), Full House Resorts Inc (AMEX:FLL), Kid Brands Inc (NYSE:KID) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its ear
CADC: 4.11 (+0.16), USPH: 39.63 (+0.60), FLL: 1.29 (unch), PICO: 21.75 (-0.03), IVAN: 1.10 (+0.01)

China ACM Reports Second Quarter Fiscal Year 2013 Results, Provides Quarterly Guidance for the Third Quarter of Fiscal Year 2013, and Updates the Yearly Guidance for Fiscal Year 2013
Marketwire - Fri Feb 15, 6:19AM CST
China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) ("China ACM" or the "Company", a provider of ready-mix concrete and related technical services in China, has announced its financial results for the second quarter of fiscal year 2013 ended December 31, 2012. The Company will host a conference call to discuss the results at 8:00 a.m., Eastern Time on February 15, 2013. Further details are provided below.
CADC: 4.11 (+0.16)

China ACM to Report the Second Quarter Fiscal Year 2013 Financial Results on February 15, 2013
Marketwire - Fri Feb 08, 12:30PM CST
China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) ("China ACM", a provider of ready-mix concrete and related technical services in China, will host a conference call with a live webcast and a full Q&A session on February 15, 2013, at 8:00 a.m., Eastern Time, to discuss financial results for the second quarter of Fiscal Year 2013.
CADC: 4.11 (+0.16)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Precious Metals and Energy Investors' Strategies

Updated Category News Views 143

Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...

Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores

Updated Category News Views 175

Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...

Continue Reading
China's New Lending Outlook: Economic Recovery Strategies

Updated Category News Views 135

China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...

Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors

Updated Category News Views 177

ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...

Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders

Updated Category News Views 259

Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....

Continue Reading